Log in

NYSE:JNJ - Johnson & Johnson Stock Price, Forecast & News

$123.16
-3.41 (-2.69 %)
(As of 03/29/2020 01:37 AM ET)
Today's Range
$120.58
Now: $123.16
$127.62
50-Day Range
$111.14
MA: $139.50
$153.53
52-Week Range
$109.16
Now: $123.16
$154.50
Volume12.13 million shs
Average Volume16.31 million shs
Market Capitalization$324.69 billion
P/E Ratio18.17
Dividend Yield3.00%
Beta0.74
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the health care field worldwide. It operates in three segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment offers baby care products under the JOHNSON'S brand; oral care products under the LISTERINE brand; beauty products under the AVEENO, CLEAN & CLEAR, DABAO, JOHNSON'S Adult, LE PETITE MARSEILLAIS, NEUTROGENA, and OGX brands; over-the-counter medicines, including acetaminophen products under the TYLENOL brand; cold, flu, and allergy products under the SUDAFED brand; allergy products under the BENADRYL and ZYRTEC brands; ibuprofen products under the MOTRIN IB brand; and acid reflux products under the PEPCID brand. This segment also provides women's health products, such as sanitary pads and tampons under the STAYFREE, CAREFREE, and o.b. brands; wound care products comprising adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. The Pharmaceutical segment offers products in various therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular and metabolic diseases. The Medical Devices segment provides orthopedic products; general surgery, biosurgical, endomechanical, and energy products; electrophysiology products to treat cardiovascular diseases; sterilization and disinfection products to reduce surgical infection; diabetes care products; and vision care products, such as disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery. The company markets its products to general public, and retail outlets and distributors, as well as distributes directly to wholesalers, hospitals, and health care professionals for prescription use. It has research and collaboration alliance with Morphic Therapeutic. The company was incorporated in 1887 and is based in New Brunswick, New Jersey.
Read More
Johnson & Johnson logo

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryPharmaceuticals
SectorMedical
CUSIP47816010
Phone732-524-0400

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$82.06 billion
Cash Flow$11.21 per share
Book Value$22.60 per share

Profitability

Net Income$15.12 billion

Miscellaneous

Employees132,200
Outstanding Shares2,636,350,000
Market Cap$324.69 billion
Next Earnings Date4/14/2020 (Confirmed)
OptionableOptionable

Receive JNJ News and Ratings via Email

Sign-up to receive the latest news and ratings for JNJ and its competitors with MarketBeat's FREE daily newsletter.


Johnson & Johnson (NYSE:JNJ) Frequently Asked Questions

How has Johnson & Johnson's stock been impacted by COVID-19 (Coronavirus)?

Johnson & Johnson's stock was trading at $131.80 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, JNJ stock has decreased by 6.6% and is now trading at $123.16. View which stocks have been mosted impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Johnson & Johnson?

14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Johnson & Johnson in the last year. There are currently 2 hold ratings and 12 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Johnson & Johnson.

When is Johnson & Johnson's next earnings date?

Johnson & Johnson is scheduled to release its next quarterly earnings announcement on Tuesday, April 14th 2020. View our earnings forecast for Johnson & Johnson.

How can I listen to Johnson & Johnson's earnings call?

Johnson & Johnson will be holding an earnings conference call on Tuesday, April 14th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were Johnson & Johnson's earnings last quarter?

Johnson & Johnson (NYSE:JNJ) released its earnings results on Wednesday, January, 22nd. The company reported $1.88 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $1.87 by $0.01. The business had revenue of $20.75 billion for the quarter, compared to the consensus estimate of $20.83 billion. Johnson & Johnson had a net margin of 22.18% and a return on equity of 39.27%. The business's revenue was up 1.7% on a year-over-year basis. During the same quarter last year, the company posted $1.97 earnings per share. View Johnson & Johnson's earnings history.

How often does Johnson & Johnson pay dividends? What is the dividend yield for Johnson & Johnson?

Johnson & Johnson announced a quarterly dividend on Thursday, January 2nd. Investors of record on Tuesday, February 25th will be paid a dividend of $0.95 per share on Tuesday, March 10th. This represents a $3.80 dividend on an annualized basis and a dividend yield of 3.09%. The ex-dividend date of this dividend is Monday, February 24th. View Johnson & Johnson's dividend history.

How will Johnson & Johnson's stock buyback program work?

Johnson & Johnson announced that its Board of Directors has authorized a share buyback program on Monday, December 17th 2018, which allows the company to buyback $5,000,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization allows the company to buy up to 1.5% of its shares through open market purchases. Shares buyback programs are typically a sign that the company's leadership believes its shares are undervalued.

What guidance has Johnson & Johnson issued on next quarter's earnings?

Johnson & Johnson updated its FY20 earnings guidance on Wednesday, January, 22nd. The company provided earnings per share guidance of $8.95-9.10 for the period, compared to the Thomson Reuters consensus EPS estimate of $9.09. The company issued revenue guidance of +4.5-5.5% yr/yr to $85.8-86.2 billion, compared to the consensus revenue estimate of $85.52 billion.

What price target have analysts set for JNJ?

14 equities research analysts have issued 12-month price objectives for Johnson & Johnson's shares. Their forecasts range from $150.00 to $173.00. On average, they expect Johnson & Johnson's stock price to reach $160.17 in the next year. This suggests a possible upside of 30.0% from the stock's current price. View analysts' price targets for Johnson & Johnson.

Has Johnson & Johnson been receiving favorable news coverage?

Headlines about JNJ stock have been trending very negative on Sunday, according to InfoTrie Sentiment. InfoTrie ranks the sentiment of news coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Johnson & Johnson earned a media sentiment score of -3.0 on InfoTrie's scale. They also assigned headlines about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the stock's share price in the next few days. View the latest news aboutJohnson & Johnson.

Are investors shorting Johnson & Johnson?

Johnson & Johnson saw a increase in short interest during the month of March. As of March 13th, there was short interest totaling 20,336,100 shares, an increase of 22.3% from the February 27th total of 16,630,000 shares. Based on an average daily volume of 7,520,000 shares, the short-interest ratio is currently 2.7 days. Currently, 0.8% of the company's stock are short sold. View Johnson & Johnson's Current Options Chain.

Who are some of Johnson & Johnson's key competitors?

What other stocks do shareholders of Johnson & Johnson own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Johnson & Johnson investors own include AT&T (T), Walt Disney (DIS), Verizon Communications (VZ), Cisco Systems (CSCO), Intel (INTC), Pfizer (PFE), Procter & Gamble (PG), JPMorgan Chase & Co. (JPM), Exxon Mobil (XOM) and The Coca-Cola (KO).

Who are Johnson & Johnson's key executives?

Johnson & Johnson's management team includes the following people:
  • Mr. Alex Gorsky, Chairman & CEO (Age 59)
  • Mr. Joseph J. Wolk CPA, Exec. VP & CFO (Age 52)
  • Dr. Paulus A. Stoffels, Chief Scientific Officer (Age 57)
  • Mr. Michael H. Ullmann, Exec. VP & Gen. Counsel (Age 60)
  • Mr. Joaquin Duato, Vice Chairman of Exec. Committee (Age 56)

What is Johnson & Johnson's stock symbol?

Johnson & Johnson trades on the New York Stock Exchange (NYSE) under the ticker symbol "JNJ."

Who are Johnson & Johnson's major shareholders?

Johnson & Johnson's stock is owned by a number of institutional and retail investors. Top institutional shareholders include State Street Corp (5.76%), Geode Capital Management LLC (1.46%), Bank of New York Mellon Corp (1.25%), Norges Bank (1.08%), Massachusetts Financial Services Co. MA (1.04%) and FMR LLC (0.68%). Company insiders that own Johnson & Johnson stock include Alex Gorsky, Charles Prince, Hubert Joly, Joaquin Duato, Kathryn E Wengel, Marillyn A Hewson, Michael E Sneed, Peter Fasolo, Ronald A Kapusta and William D Perez. View institutional ownership trends for Johnson & Johnson.

Which major investors are selling Johnson & Johnson stock?

JNJ stock was sold by a variety of institutional investors in the last quarter, including Capital World Investors, Capital International Investors, Renaissance Technologies LLC, Assenagon Asset Management S.A., Yacktman Asset Management LP, Great West Life Assurance Co. Can, Nuveen Asset Management LLC, and Standard Life Aberdeen plc. Company insiders that have sold Johnson & Johnson company stock in the last year include Kathryn E Wengel, and Michael E Sneed. View insider buying and selling activity for Johnson & Johnson.

Which major investors are buying Johnson & Johnson stock?

JNJ stock was purchased by a variety of institutional investors in the last quarter, including Norges Bank, Johanson Financial Advisors Inc., Amundi Pioneer Asset Management Inc., M&G Investment Management Ltd., Alliancebernstein L.P., Geode Capital Management LLC, Franklin Resources Inc., and Bank of New York Mellon Corp. Company insiders that have bought Johnson & Johnson stock in the last two years include Charles Prince, Hubert Joly, Marillyn A Hewson, and William D Perez. View insider buying and selling activity for Johnson & Johnson.

How do I buy shares of Johnson & Johnson?

Shares of JNJ can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Johnson & Johnson's stock price today?

One share of JNJ stock can currently be purchased for approximately $123.16.

How big of a company is Johnson & Johnson?

Johnson & Johnson has a market capitalization of $324.69 billion and generates $82.06 billion in revenue each year. The company earns $15.12 billion in net income (profit) each year or $8.68 on an earnings per share basis. Johnson & Johnson employs 132,200 workers across the globe. View additional information about Johnson & Johnson.

What is Johnson & Johnson's official website?

The official website for Johnson & Johnson is http://www.jnj.com/.

How can I contact Johnson & Johnson?

Johnson & Johnson's mailing address is ONE JOHNSON & JOHNSON PLZ, NEW BRUNSWICK NJ, 08933. The company can be reached via phone at 732-524-0400.


MarketBeat Community Rating for Johnson & Johnson (NYSE JNJ)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  966 (Vote Outperform)
Underperform Votes:  1,024 (Vote Underperform)
Total Votes:  1,990
MarketBeat's community ratings are surveys of what our community members think about Johnson & Johnson and other stocks. Vote "Outperform" if you believe JNJ will outperform the S&P 500 over the long term. Vote "Underperform" if you believe JNJ will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 3/29/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel